Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,974,911
+$936,912 QoQ
Shares Held
3,314
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#1,892
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NVWM, LLC holds $14,587,392 across 12 Drug Manufacturers - General names. LLY ranks #2 (27.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
32,439 | $4,168,411 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
3,314 | $3,974,911 | |
| 3 | JNJ |
Johnson & Johnson
|
13,755 | $3,493,356 | |
| 4 | ABBV |
AbbVie Inc.
|
11,341 | $2,853,848 | |
| 5 | PFE |
Pfizer Inc
|
2,948 | $70,987 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
48 | $6,064 | |
| 7 | AMGN |
Amgen Inc
|
16 | $5,793 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
93 | $5,357 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,974,911 | 3,314 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,037,999 | 3,303 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,490,560 | 3,248 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,523,241 | 3,307 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $3,837,626 | 4,923 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,953,630 | 4,787 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,802,100 | 4,925 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $4,404,892 | 4,972 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $4,610,194 | 5,092 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,087,401 | 5,254 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,174,581 | 5,446 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,076,143 | 5,727 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $2,789,023 | 5,947 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,218,493 | 6,460 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,347,229 | 6,416 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,180,671 | 6,744 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,383,812 | 4,268 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,224,231 | 4,275 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,097,697 | 3,974 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $835,014 | 3,614 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $1,044,544 | 4,551 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $847,227 | 4,535 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $718,920 | 4,258 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $709,903 | 4,796 | Shares | Sole | 2020-12-10 | |
| 2020-06-30 | $697,436 | 4,248 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $585,259 | 4,219 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||